Star Sports Medicine to Convene 17 Aug Board Meeting for H1 2026 Results and Dividend Deliberation

Bulletin Express
08/05

Star Sports Medicine Co., Ltd. (Star Sports Medicine) has scheduled a board meeting for Monday, 17 August 2026. Directors will review and approve the unaudited interim results for the six-month period ended 30 June 2026 and decide on the declaration of an interim dividend, if any.

The meeting notice was issued by Chairman and Executive Director Mr. Dong Wenxing on 5 August 2026. As of the date of the announcement, the Board comprises:

• Executive Directors: Mr. Dong Wenxing, Mr. He Lu • Non-executive Directors: Ms. Zhang Di, Mr. Chang Xi, Mr. David Guowei Wang, Ms. Yi Lin, Mr. Zhou Quan • Independent Non-executive Directors: Mr. Lyu Zhenlin, Mr. Deng Yu, Mr. Liu Baojie, Mr. Wang Chunfei

No financial metrics or dividend figures were disclosed in the notice. The company will release its interim financial report following board approval.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10